BRIACELL THERAPEUTICS CORP. Cash And Cash Equivalents
BRIACELL THERAPEUTICS CORP. (BCTX) had Cash And Cash Equivalents of $44.53 million as of 2022-04-30, per its 6-K filed 2022-06-13.
Discontinued › Balance Sheet › Assets, Current
ifrs-full:CashAndCashEquivalents · last filed 2022-06-13
- 2020-07-31: Cash And Cash Equivalents 26.10K CAD.
- 2019-08-01: Cash And Cash Equivalents 192.92K CAD.
CAD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2020-07-31 | 26.10K CAD 40-F/A · filed 2021-11-16 |
| 2019-08-01 | 192.92K CAD 40-F/A · filed 2021-11-16 |
USD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2022-04-30 | $44.53M 6-K · filed 2022-06-13 |
| 2022-01-31 | $47.98M 6-K · filed 2022-03-15 |
| 2021-07-31 | $57.27M 6-K · filed 2022-06-13 |
| 2021-04-30 | $20.06M 6-K · filed 2022-06-13 |
| 2021-01-31 | $5.95K 6-K · filed 2022-03-15 |
| 2020-07-31 | $21.25K 6-K · filed 2022-06-13 |
| 2019-08-01 | $157.03K 40-F/A · filed 2021-11-16 |
| 2019-07-29 | $763.90K 40-F/A · filed 2021-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |